NO983871D0 - Oksa- og tiadiazol muskarinreseptorantagonister - Google Patents

Oksa- og tiadiazol muskarinreseptorantagonister

Info

Publication number
NO983871D0
NO983871D0 NO983871A NO983871A NO983871D0 NO 983871 D0 NO983871 D0 NO 983871D0 NO 983871 A NO983871 A NO 983871A NO 983871 A NO983871 A NO 983871A NO 983871 D0 NO983871 D0 NO 983871D0
Authority
NO
Norway
Prior art keywords
thiadiazole
oxa
receptor antagonists
muscarinic receptor
muscarinic
Prior art date
Application number
NO983871A
Other languages
English (en)
Other versions
NO313414B1 (no
NO983871L (no
Inventor
Alexander Roderick Mackenzie
Anthony Wood
Robert John Bass
Original Assignee
Pfizer Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev
Publication of NO983871D0 publication Critical patent/NO983871D0/no
Publication of NO983871L publication Critical patent/NO983871L/no
Publication of NO313414B1 publication Critical patent/NO313414B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO19983871A 1996-02-22 1998-08-21 Oksa- og tiadiazol muskarinreseptorantagonister NO313414B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9603755.1A GB9603755D0 (en) 1996-02-22 1996-02-22 Therapeutic agents
PCT/EP1997/000525 WO1997030994A1 (en) 1996-02-22 1997-02-04 Oxa- and thia-diazole muscarinic receptor antagonists

Publications (3)

Publication Number Publication Date
NO983871D0 true NO983871D0 (no) 1998-08-21
NO983871L NO983871L (no) 1998-08-21
NO313414B1 NO313414B1 (no) 2002-09-30

Family

ID=10789217

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19983871A NO313414B1 (no) 1996-02-22 1998-08-21 Oksa- og tiadiazol muskarinreseptorantagonister

Country Status (43)

Country Link
US (1) US5977142A (no)
EP (1) EP0885218B1 (no)
JP (1) JP3148252B2 (no)
KR (1) KR100315934B1 (no)
CN (1) CN1089340C (no)
AP (1) AP751A (no)
AR (1) AR005916A1 (no)
AT (1) ATE200899T1 (no)
AU (1) AU712230B2 (no)
BG (2) BG102699A (no)
BR (1) BR9707733A (no)
CA (1) CA2247164C (no)
CO (1) CO4650040A1 (no)
CZ (1) CZ292650B6 (no)
DE (1) DE69704701T2 (no)
DK (1) DK0885218T3 (no)
DZ (1) DZ2181A1 (no)
ES (1) ES2156357T3 (no)
GB (1) GB9603755D0 (no)
GR (1) GR3036032T3 (no)
HK (1) HK1018274A1 (no)
HN (1) HN1997000020A (no)
HR (1) HRP970098B1 (no)
HU (1) HUP9900501A3 (no)
ID (1) ID16642A (no)
IL (1) IL125413A (no)
IS (1) IS4803A (no)
MY (1) MY129729A (no)
NO (1) NO313414B1 (no)
NZ (1) NZ331039A (no)
OA (1) OA10838A (no)
PE (1) PE42798A1 (no)
PL (1) PL186879B1 (no)
PT (1) PT885218E (no)
RU (1) RU2162848C2 (no)
SK (1) SK283461B6 (no)
TN (1) TNSN97039A1 (no)
TR (1) TR199801644T2 (no)
TW (1) TW492961B (no)
UA (1) UA61068C2 (no)
WO (1) WO1997030994A1 (no)
YU (1) YU35698A (no)
ZA (1) ZA971513B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6107313A (en) * 1998-10-02 2000-08-22 Combichem, Inc. Dopamine receptor antagonists
GB0510141D0 (en) * 2005-05-18 2005-06-22 Addex Pharmaceuticals Sa Novel compounds B3
GB0510139D0 (en) * 2005-05-18 2005-06-22 Addex Pharmaceuticals Sa Novel compounds B1
GB0516313D0 (en) 2005-08-08 2005-09-14 Argenta Discovery Ltd Azole derivatives and their uses
WO2008017827A2 (en) * 2006-08-08 2008-02-14 Argenta Discovery Limited Azole and thiazole derivatives and their uses
WO2008023157A1 (en) * 2006-08-21 2008-02-28 Argenta Discovery Limited Nitrogen containing heterocyclic compounds useful as m3-receptor modulators
WO2008096093A1 (en) * 2007-02-06 2008-08-14 Argenta Discovery Ltd. Oxazole and thiazole derivatives and their uses
GB0702382D0 (en) * 2007-02-07 2007-03-21 Argenta Discovery Ltd New salt
GB0702416D0 (en) * 2007-02-07 2007-03-21 Argenta Discovery Ltd New combination
GB0702414D0 (en) * 2007-02-07 2007-03-21 Argenta Discovery Ltd Oxazole and thiazole derivatives and their uses 2
GB0702385D0 (en) * 2007-02-07 2007-03-21 Argenta Discovery Ltd New combination
US7846955B2 (en) * 2007-02-07 2010-12-07 Astrazeneca Ab Salt
CN101657452A (zh) * 2007-02-15 2010-02-24 阿金塔探索有限公司 作为m3毒蕈碱性受体的杂环衍生物
WO2009098453A1 (en) * 2008-02-06 2009-08-13 Astrazeneca Ab Azonia bicycloalkanes as m3 muscarinic acetylcholin receptor antagonists
US8263623B2 (en) 2008-07-11 2012-09-11 Pfizer Inc. Triazol derivatives useful for the treatment of diseases
WO2010018352A1 (en) * 2008-08-12 2010-02-18 Argenta Discovery Limited Heterocyclic compounds used in the treatment of diseases where enhanced m3 receptor activation is implicated
JP2014065387A (ja) * 2012-09-25 2014-04-17 Showa Corp 自動二輪車の車高調整装置

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ219646A (en) * 1986-03-27 1990-10-26 Merck Sharp & Dohme Oxadiazole derivatives of azacyclics for treating cns disorders
IL88846A0 (en) * 1988-01-08 1989-07-31 Merck Sharp & Dohme Lipophilic oxadiazoles,their preparation and pharmaceutical compositions containing them
US5043345A (en) * 1989-02-22 1991-08-27 Novo Nordisk A/S Piperidine compounds and their preparation and use
WO1993013083A1 (en) * 1991-12-31 1993-07-08 Fujisawa Pharmaceutical Co., Ltd. Oxadiazole derivatives having acetylcholinesterase-inhibitory and muscarinic agonist activity
TW360653B (en) * 1995-03-01 1999-06-11 Janssen Pharmaceutica Nv A oxadiazole compound having colon motility stimulating properties, its preparation process and its pharmaceutical composition

Also Published As

Publication number Publication date
US5977142A (en) 1999-11-02
DZ2181A1 (fr) 2002-12-01
AR005916A1 (es) 1999-07-21
AP751A (en) 1999-07-12
ZA971513B (en) 1998-08-21
SK283461B6 (sk) 2003-08-05
DE69704701D1 (de) 2001-06-07
IL125413A0 (en) 1999-03-12
IS4803A (is) 1998-07-21
PT885218E (pt) 2001-08-30
TW492961B (en) 2002-07-01
HUP9900501A3 (en) 2001-02-28
KR100315934B1 (ko) 2002-03-21
JP3148252B2 (ja) 2001-03-19
MY129729A (en) 2007-04-30
OA10838A (en) 2001-08-13
CZ292650B6 (cs) 2003-11-12
CO4650040A1 (es) 1998-09-03
HK1018274A1 (en) 1999-12-17
BR9707733A (pt) 1999-07-27
AU1601497A (en) 1997-09-10
NO313414B1 (no) 2002-09-30
DE69704701T2 (de) 2001-08-16
ATE200899T1 (de) 2001-05-15
HUP9900501A2 (hu) 1999-06-28
GR3036032T3 (en) 2001-09-28
CA2247164A1 (en) 1997-08-28
HRP970098A2 (en) 1999-04-30
EP0885218A1 (en) 1998-12-23
CN1211981A (zh) 1999-03-24
AU712230B2 (en) 1999-11-04
SK112398A3 (en) 2000-04-10
AP9700930A0 (en) 1997-04-30
HN1997000020A (es) 1997-06-05
YU35698A (sh) 1999-07-28
HRP970098B1 (en) 2001-12-31
ES2156357T3 (es) 2001-06-16
PL186879B1 (pl) 2004-03-31
JPH11504051A (ja) 1999-04-06
CZ267898A3 (cs) 1999-08-11
EP0885218B1 (en) 2001-05-02
NO983871L (no) 1998-08-21
GB9603755D0 (en) 1996-04-24
TR199801644T2 (xx) 1998-11-23
RU2162848C2 (ru) 2001-02-10
CN1089340C (zh) 2002-08-21
KR19990087143A (ko) 1999-12-15
NZ331039A (en) 1999-10-28
ID16642A (id) 1997-10-23
DK0885218T3 (da) 2001-05-28
BG63971B1 (bg) 2003-08-29
CA2247164C (en) 2004-11-16
PE42798A1 (es) 1998-08-18
IL125413A (en) 2002-09-12
UA61068C2 (en) 2003-11-17
TNSN97039A1 (fr) 2005-03-15
WO1997030994A1 (en) 1997-08-28
BG102699A (en) 1999-09-30
PL328633A1 (en) 1999-02-15

Similar Documents

Publication Publication Date Title
DE69719354D1 (de) Muscarin-antagonisten
DE69734833D1 (de) Vitronektin rezeptor antagonisten
NO983871L (no) Oksa- og tiadiazol muskarinreseptorantagonister
NO972016D0 (no) Indolyl-Y-reseptorantagonister
DE69812096D1 (de) Neuropeptid y rezeptorantagonisten
BR9508178A (pt) Antagonistas de receptor de vitronectina
DE69728392D1 (de) Indolderivate verwendbar als endothelinrezeptorantagonisten
BR9407933A (pt) Antagonistas de receptores de endotelina
PT1131291E (pt) Antagonistas iii do receptor 4-aroil-piperidin-ccr-3
GB9020051D0 (en) Muscarinic receptor antagonists
NO993350D0 (no) Vitronectin-reseptor-antagonister
AU6031001A (en) Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
SG80041A1 (en) Muscarinic receptor antagonists
IL152701A0 (en) Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
ID24726A (id) Antagonis-antagonis reseptor trombin
ID24162A (id) Antagonis-antagonis reseptor vitronektin
DK0906294T3 (da) Benzoxazinon-dopamin D4-receptor-antagonister
BR9507220A (pt) Antagonistas de receptores de endotelina
GB9521696D0 (en) Combination of LTD4 receptor antagonists with glucocorticosteriods
DE69427921D1 (de) Epsilon opioid rezeptor und dessen verwendungen
DE60009931D1 (de) Muscarin-antagonisten
DE69616364D1 (de) Endothelinrezeptorantagonisten
AU3935897A (en) B1-bradykinin receptor antagonists and use thereof
TR199601082A3 (tr) Entegrin reseptör antagonistleri.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees